[The clinical usefulness of the serological study of IgG antibodies and IgA against the antigens associated with the Epstein-Barr virus in patients with nasopharyngeal carcinoma].
The relationship between nasopharyngeal carcinoma (NPC) and Epstein-Barr virus (EBV) has been already well established. Titulation of the antibodies IgG and IgA against EBV-related antigens has been proved reliable but always suitable having tested and age-matched control population. We present here the preliminary results from the 14 patients bearing NPC and 12 patients with other carcinoma of the head and neck and healthy donors.
Amador García
J M
JM
Servicio de Otorrinolaringología, Hospital del SAS, Virgen de las Nieves, Granada.
Mendoza Montero
J
J
Expósito Hernández
J
J
Salinero Hernández
J
J
Esquivias López-Cuerpo
J
J
Ballesteros García
P
P
D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000097:blood*; D000956:Antigens, Viral / Q000276:immunology*; D002213:Capsid / Q000276:immunology; D002277:Carcinoma / Q000276:immunology*; D005260:Female; D006258:Head and Neck Neoplasms / Q000276:immunology; D004854:Herpesvirus 4, Human / Q000276:immunology*; D006801:Humans; D007074:Immunoglobulin G / Q000097:blood*; D008297:Male; D008875:Middle Aged; D009303:Nasopharyngeal Neoplasms / Q000276:immunology*
D000914:Antibodies, Viral; D000956:Antigens, Viral; C033305:Epstein-Barr virus early antigen; D007074:Immunoglobulin G
Utilidad clínica del estudio serológico de anticuerpos IgG e IgA antiantígenos asociados al virus de Epstein-Barr en pacientes con carcinoma de nasofaringe.